| Literature DB >> 32554360 |
Tamara Herrera-Fortin1, Raluca Pana1, Ewa Wesolowska1, Josiane Bourré-Tessier1, Dang K Nguyen1.
Abstract
Porphyrias are rare genetic disorders which cause a deficiency in the enzymes involved in the biosynthesis of heme. The treatment of epilepsy in patients with acute intermittent porphyria can be difficult since many anticonvulsants can increase heme synthesis and trigger porphyric attacks. We report a patient with focal epilepsy successfully treated with eslicarbazepine without exacerbation of porphyria.Entities:
Keywords: carbamazepine; eslicarbazepine; hepatic porphyria
Mesh：
Substances：
Year: 2020 PMID： 32554360 DOI： 10.1684/epd.2020.1171
Source DB: PubMed Journal: Epileptic Disord ISSN： 1294-9361 Impact factor: 1.819